FIELD: medicine.
SUBSTANCE: invention refers to indole-3-yl-carbonyl-spiro-piperidine derivatives which have an effect of Vla-receptor antagonists and are presented by Formula I: 
where a tail spiropiperidine group A and residual R1, R2 and R3 are such as specified in the patent claim.
EFFECT: higher efficiency of applying the compounds in drugs effective in dysmenorrhea, hypertension, chronic heart failure, inadequate vasopressin secretion, hepatic cirrhosis, nephrotic syndrome, obsessive-compulsive disorder, anxious and depressive disorders.
22 cl, 42 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDOL-3-YL-CARBONYL-ASASPIRO DERIVATIVES AS VASOPRESSIN RECEPTOR ANTAGONISTS | 2006 |
|
RU2418801C2 |
| INDOLE-3-CARBONYL-SPIRO-PIPERADINE DERIVATIVES AS V1a RECEPTOR ANTAGONISTS | 2006 |
|
RU2414466C2 |
| INDOL-3-YL-CARBONYL-PIPERADINE-BENZIMIDAZOLE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS | 2006 |
|
RU2415139C2 |
| INDOLE-3-YL-CARBONYL-PIPERIDINE AND PIPERAZINE DERIVATIVES | 2006 |
|
RU2422442C2 |
| ANTAGONISTS OF PEPTIDE RECEPTOR FIXED WITH CALCITONIN GENE | 2003 |
|
RU2341526C2 |
| NOVEL BICYCLIC DERIVATIVES | 2020 |
|
RU2830113C2 |
| 2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
| OXAZINMONOACYLGLYCERIN LIPASE (MAGL) INHIBITORS | 2019 |
|
RU2794334C2 |
| SPIROINDOLINONE DERIVATIVES | 2007 |
|
RU2435771C2 |
| DERIVATIVES OF INDOLE ORDER AS p38 KINASE INHIBITORS | 2000 |
|
RU2278115C2 |
